FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894849225> ?p ?o ?g. }

• W2894849225 endingPage "80" @default.
• W2894849225 startingPage "66" @default.
• W2894849225 abstract "Hepatocellular injury is the pathological hallmark of hepatitis and a crucial driver for the progression of liver diseases, while the treatment options are commonly restricted. Interleukin-22 (IL-22) has attracted special attention as a potent survival factor for hepatocytes that both prevents and repairs the injury of hepatocytes through activation of STAT3 signaling pathway. We hypothesized that the ability to generate potent expression of IL-22 locally for the treatment of severe hepatocellular injury in hepatitis was a promising strategy to enhance efficacy and overcome off-target effects. Accordingly, we developed a polypeptide penetratin-based hybrid nanoparticle system (PDPIA) carrying IL-22 gene by a self-assembly process. This nanocomplex modified with penetratin featured direct translocation across the cellular or endosomal membrane but mild zeta-potential to facilitate the high cellular internalization and endosomal escape of the gene cargos as well as scarcely Kupffer cells uptake. More importantly, PDPIA afforded preferential liver accumulation and predominant hepatocytes internalization following systemic administration, which showed pharmacologically suitable organ and sub-organ-selective properties. Subsequent studies confirmed a considerable protective role of PDPIA in a model of severe hepatitis induced by concanavalin A, evidenced by reduced hepatocellular injury and evaded immune response. The locally expressed IL-22 by PDPIA activated STAT3/Erk signal transduction, and thus promoted hepatocyte regeneration, inhibited reactive oxygen species (ROS) accumulation as well as prevented the dysfunction of mitochondrial. In addition, this system did not manifest side effects or systemic toxicity in mice. Collectively, the high versatility of PDPIA rendered its promising applications might be an effective agent to treat various hepatic disorders." @default.
• W2894849225 created "2018-10-12" @default.
• W2894849225 creator A5002367111 @default.
• W2894849225 creator A5002905980 @default.
• W2894849225 creator A5017541508 @default.
• W2894849225 creator A5034242696 @default.
• W2894849225 creator A5051500081 @default.
• W2894849225 creator A5053586216 @default.
• W2894849225 creator A5055279293 @default.
• W2894849225 creator A5062559032 @default.
• W2894849225 creator A5064584608 @default.
• W2894849225 creator A5065085069 @default.
• W2894849225 creator A5077956304 @default.
• W2894849225 creator A5080044735 @default.
• W2894849225 creator A5082814141 @default.
• W2894849225 creator A5091239610 @default.
• W2894849225 date "2018-12-01" @default.
• W2894849225 modified "2023-10-16" @default.
• W2894849225 title "In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics" @default.
• W2894849225 cites W1125796620 @default.
• W2894849225 cites W1490477754 @default.
• W2894849225 cites W1843302206 @default.
• W2894849225 cites W1928416950 @default.
• W2894849225 cites W1966060470 @default.
• W2894849225 cites W1977039417 @default.
• W2894849225 cites W1977839816 @default.
• W2894849225 cites W2003470252 @default.
• W2894849225 cites W2006076866 @default.
• W2894849225 cites W2010777443 @default.
• W2894849225 cites W2019889336 @default.
• W2894849225 cites W2021307619 @default.
• W2894849225 cites W2022564018 @default.
• W2894849225 cites W2029041094 @default.
• W2894849225 cites W2039551908 @default.
• W2894849225 cites W2044229386 @default.
• W2894849225 cites W2051820513 @default.
• W2894849225 cites W2053626384 @default.
• W2894849225 cites W2062564526 @default.
• W2894849225 cites W2064093384 @default.
• W2894849225 cites W2067302150 @default.
• W2894849225 cites W2085380241 @default.
• W2894849225 cites W2091845172 @default.
• W2894849225 cites W2093198351 @default.
• W2894849225 cites W2094842452 @default.
• W2894849225 cites W2102619095 @default.
• W2894849225 cites W2112220475 @default.
• W2894849225 cites W2118878458 @default.
• W2894849225 cites W2160775206 @default.
• W2894849225 cites W2169378111 @default.
• W2894849225 cites W2177257101 @default.
• W2894849225 cites W2219694198 @default.
• W2894849225 cites W2269090499 @default.
• W2894849225 cites W2322975299 @default.
• W2894849225 cites W2328516329 @default.
• W2894849225 cites W2343671091 @default.
• W2894849225 cites W2344644350 @default.
• W2894849225 cites W2442031947 @default.
• W2894849225 cites W2464205017 @default.
• W2894849225 cites W2473633774 @default.
• W2894849225 cites W2512127469 @default.
• W2894849225 cites W2515394036 @default.
• W2894849225 cites W2517826025 @default.
• W2894849225 cites W2522038806 @default.
• W2894849225 cites W2593777183 @default.
• W2894849225 cites W2598434792 @default.
• W2894849225 cites W2599186163 @default.
• W2894849225 cites W2613317222 @default.
• W2894849225 cites W2617500612 @default.
• W2894849225 cites W2724420731 @default.
• W2894849225 cites W2754950412 @default.
• W2894849225 cites W2759920093 @default.
• W2894849225 cites W2763622116 @default.
• W2894849225 cites W2765736556 @default.
• W2894849225 cites W2771431069 @default.
• W2894849225 cites W2809723856 @default.
• W2894849225 cites W4231144652 @default.
• W2894849225 doi "https://doi.org/10.1016/j.biomaterials.2018.09.046" @default.
• W2894849225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30296739" @default.
• W2894849225 hasPublicationYear "2018" @default.
• W2894849225 type Work @default.
• W2894849225 sameAs 2894849225 @default.
• W2894849225 citedByCount "24" @default.
• W2894849225 countsByYear W28948492252019 @default.
• W2894849225 countsByYear W28948492252020 @default.
• W2894849225 countsByYear W28948492252021 @default.
• W2894849225 countsByYear W28948492252022 @default.
• W2894849225 countsByYear W28948492252023 @default.
• W2894849225 crossrefType "journal-article" @default.
• W2894849225 hasAuthorship W2894849225A5002367111 @default.
• W2894849225 hasAuthorship W2894849225A5002905980 @default.
• W2894849225 hasAuthorship W2894849225A5017541508 @default.
• W2894849225 hasAuthorship W2894849225A5034242696 @default.
• W2894849225 hasAuthorship W2894849225A5051500081 @default.
• W2894849225 hasAuthorship W2894849225A5053586216 @default.
• W2894849225 hasAuthorship W2894849225A5055279293 @default.
• W2894849225 hasAuthorship W2894849225A5062559032 @default.
• W2894849225 hasAuthorship W2894849225A5064584608 @default.
• W2894849225 hasAuthorship W2894849225A5065085069 @default.

• next